Work

FIGURE 3 from Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in Breast Cancer

Year: 2024

Type: other

Abstract: Impact of PDXs on activation status of select signaling molecules in skeletal muscle. A, Tumors from ER+/PR+ tumor cells reduced AKT phosphorylation in skeletal muscle. B, AKT protein levels in skeletal muscles were not affected by tumors. C, PTEN protein levels in skeletal muscles were not changed by tumors, compared with the control group. D, TNBC-derived PDX upregulated phospho-p38 in skeletal muscle. E, Tumors did not affect total p-38 protein levels in skeletal muscle. Quantification of western blotting was performed using NIH ImageJ software 1.X.

DOI: 10.1158/2767-9764.25826872.v1

Authors: Ruizhong Wang, Aditi S. Khatpe, Brijesh Kumar, Henry Elmer Mang, Katie Batic, Adedeji K. Adebayo, Harikrishna Nakshatri

Language: English

Topic: Muscle Physiology and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4396921729

Cites:

Cited by:

Related to: 10